Blood Res.  2016 Mar;51(1):1-2. 10.5045/br.2016.51.1.1.

Application of next generation sequencing in the diagnosis and management of mast cell leukemia

• Kim J

• KMID: 2172735
• DOI: http://doi.org/10.5045/br.2016.51.1.1

Abstract

No abstract available.

MeSH Terms

Diagnosis*
Leukemia, Mast-Cell*
Mast Cells*

Reference

1. Heybeli C. Mast cells, mastocytosis, and related disorders. N Engl J Med. 2015; 373:1885. PMID: 26535531.

2. Chantorn R, Shwayder T. Death from mast cell leukemia: a young patient with longstanding cutaneous mastocytosis evolving into fatal mast cell leukemia. Pediatr Dermatol. 2012; 29:605–609. PMID: 22329485.

3. Hermans MA, Rietveld MJ, van Laar JA, et al. Systemic mastocytosis: A cohort study on clinical characteristics of 136 patients in a large tertiary centre. Eur J Intern Med. 2016; [Epub ahead of print].

4. Ustun C, Smith A, Cayci Z, et al. Allogeneic hematopoietic cell transplantation in systemic mastocytosis: Is there a high risk for veno-occlusive disease. Eur J Haematol. 2015; [Epub ahead of print].

5. Arock M, Sotlar K, Akin C, et al. KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis. Leukemia. 2015; 29:1223–1232. PMID: 25650093.

6. Jawhar M, Schwaab J, Schnittger S, et al. Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis. Leukemia. 2016; 30:136–143. PMID: 26464169.

7. Youk J, Koh Y, Kim J, et al. A scientific treatment approach for acute mast cell leukemia: Using a strategy based on next-generation sequencing data. Blood Res. 2016; 51:17–22.

8. Spector MS, Iossifov I, Kritharis A, et al. Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor β chain and KIT V654A. Leukemia. 2012; 26:1422–1425. PMID: 22173243.

9. Georgin-Lavialle S, Lhermitte L, Dubreuil P, Chandesris MO, Hermine O, Damaj G. Mast cell leukemia. Blood. 2013; 121:1285–1295. PMID: 23243287.